Antiretroviral therapy for HIV should be started at diagnosis regardless of CD4+ count, study concludesBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h3943 (Published 21 July 2015) Cite this as: BMJ 2015;351:h3943
- Jacqui Wise
Initiating antiretroviral therapy immediately after HIV diagnosis rather than waiting until a patient’s CD4+ count has declined is of considerable benefit, a large international study published in the New England Journal of Medicine has found.1 The results of the study were also released at the International AIDS Society conference in Vancouver, Canada, on 20 July.
It has been common practice to defer the start of antiretroviral therapy in asymptomatic patients with a CD4+ count above a certain threshold. The threshold for treatment varies across different …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial